Filing Details

Accession Number:
0001181431-13-063458
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-18 18:59:48
Reporting Period:
2013-12-16
Filing Date:
2013-12-18
Accepted Time:
2013-12-18 18:59:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1392380 Gevo Inc. GEVO Industrial Organic Chemicals (2860) 870747704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1083218 Ganesh Kishore Gevo, Inc., 345 Inverness Drive South
Building C, Suite 310
Englewood CO 80112
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-16 37,037 $0.00 89,295 No 4 P Direct
Common Stock Acquisiton 2013-12-16 370,370 $0.00 2,041,795 No 4 P Indirect See foonote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect See foonote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant (right to buy) Acquisiton 2013-12-16 37,037 $0.00 37,037 $1.85
Common Stock Common Stock Warrant (right-to-buy) Acquisiton 2013-12-16 370,370 $0.00 370,370 $1.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,037 2013-12-16 2018-12-16 No 4 P Direct
370,370 2013-12-16 2018-12-16 No 4 P Indirect
Footnotes
  1. The shares of common stock and the warrants to purchase common stock were purchased together as common stock units, but were issued separately. Each common stock unit consisted of one share of common stock and a warrant to purchase one share of common stock, at a public offering price of $1.35 per common stock unit. Each warrant has an exercise price of $1.85 per share (subject to adjustment in certain circumstances), became exercisable on the date of original issuance and will expire on December 16, 2018.
  2. The reporting person is deemed to be the beneficial owner of shares held by Malaysian Life Sciences Capital Fund Ltd. as previously reported on the Form 4 filed February 15, 2011.